- Is Dalteparin Safe in Patients with Acute Coronary Syndrome?
-
Kim JH, Jeong MH
- KMID: 1858771
- Korean Circ J.
- 2003 Aug;33(8):653-655.
- doi: 10.4070/kcj.2003.33.8.653
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Rectus Sheath Hematoma and Pelvic Cavity Hematoma Induced by Dalteparin Injection
-
Ryu SW, Lee MY, Ham NS, Kim KH, Lee NS, Won JH, Park HS
- KMID: 2267779
- Korean J Med.
- 2013 Nov;85(5):530-534.
Rectus sheath hematoma (RSH) is an uncommon condition caused by hemorrhage into the rectus sheath. RSH is characterized by abdominal pain and an abdominal mass. This condition is associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prophylaxis of Venous Thromboembolism in Korean Patients with Total Knee Replacement Arthroplasty
-
Lee JK, Chung KS, Baek SW, Choi CH
- KMID: 2185383
- J Korean Orthop Assoc.
- 2012 Apr;47(2):86-95.
- doi: 10.4055/jkoa.2012.47.2.86
PURPOSE: To evaluate the effects and problems of venous thromboembolism (VTE) prophylaxis with a reduced dosage and administration period in Korean total knee arthroplasty (TKA) patients. MATERIALS AND METHODS: We analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Presentation of Adverse Drug Reaction of Dalteparin in Acute Coronary Syndrome
-
Hwang ES, Chae IH, Park KW, Kim YS, Choi JO, Oh SI, Kim CH, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS
- KMID: 1858772
- Korean Circ J.
- 2003 Aug;33(8):656-662.
- doi: 10.4070/kcj.2003.33.8.656
BACKGROUND AND OBJECTIVES: Heparin is crucial in the treatment of acute coronary syndrome. However, unfractionated heparin has pharmacokinetic, biophysical and biological limitations, but its low molecular weight has been used... -
- CITED
-
- Close
- SHARE
-
- Close
- A Study on the Efficacy and Safety of Rivaroxaban in Urologic Cancer-Associated Venous Thromboembolism
-
Lee JH, You D, Lee SD, Oh YM, Lee JS
- KMID: 2470403
- Korean J Urol Oncol.
- 2019 Dec;17(3):178-185.
- doi: 10.22465/kjuo.2019.17.3.178
PURPOSE: Although direct oral anticoagulants (DOACs) are recommended as an alternative to low-molecular weighted heparin for cancer-associated venous thromboembolism (VTE), there is no firm evidence on the efficacy and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparisons of Bleeding Risks between Rivaroxaban and Dalteparin for Treatment of Venous Thromboembolism in Cancer Patients
-
Kim YK, An SH, Kim JY, Chung JE, Gwak HS
- KMID: 2358234
- Korean J Clin Pharm.
- 2016 Sep;26(3):195-200.
- doi: 10.0000/kjcp.2016.26.3.195
BACKGROUND: Venous thromboembolism (VTE) is a common and life-threating condition in cancer patients. Low molecular weight heparins (LMWH), such as dalteparin, are recommended in the treatment of VTE. Also, rivaroxaban,... -
- CITED
-
- Close
- SHARE
-
- Close
- Thromboembolic Events as Prognostic Clinical Markers in Advanced Pancreatic and Biliary Tract Cancer
-
Shin K, Lee MA
- KMID: 2446988
- Korean J Med.
- 2018 Oct;93(5):457-463.
- doi: 10.3904/kjm.2018.93.5.457
BACKGROUND/AIMS: Venous thromboembolic events (VTEs) are common events in patients with advanced cancer. We analyzed the clinical characteristics of VTEs in advanced pancreatic and biliary tract cancer to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- Dalteparin sodium-associated retroperitoneal hematoma in a patient with diabetic nephropathy
-
Jeong TK, Jeong GH, Park BS, Ma SK, Kim SW, Kim NH, Choi KC
- KMID: 2306062
- Korean J Med.
- 2003 Mar;64(3):322-327.
Retroperitoneal Hematoma is a rare intraabdominal bleeding occurring in patients with low- molecular weight heparin anti-coagulant therapy. We report a case of dalteparin sodium-associated retroperitoneal hematoma in a 70-year-old man... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Effects of Abciximab Combined with Dalteparin for High-Risk Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
-
Hwang SH, Jeong MH, Kim W, Hong YJ, Park HW, Sohn IS, Kim KH, Kim JH, Ahn YK, Cho JG, Kim HG, Kim W, Park JC, Kang JC
- KMID: 2028997
- Korean Circ J.
- 2006 Mar;36(3):184-191.
- doi: 10.4070/kcj.2006.36.3.184
BACKGROUND AND OBJECTIVES: The therapeutic efficacy of combined platelet glycoprotein IIb/IIIa receptor blocker with low molecular weight heparin (LMWH) is unknown for patients with acute myocardial infarction (AMI) and who... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Myocardial Infarction due to Sepsis in a Renal Allograft Recipient
-
Back IH, Lee TW, Hong SP, Lim CK, Kim MJ
- KMID: 2307321
- Korean J Nephrol.
- 1999 Sep;18(5):830-835.
Despite improvements in surgical technique, immunosuppressive therapy, and follow-up care, a considerable number of patients with kidney transplants die as a consequence of sepsis and throm-boembolism. The incidence of thromboembolism... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Generalized Urticaria Induced by Heparin during Hemodialysis
-
- KMID: 2299581
- Korean J Asthma Allergy Clin Immunol.
- 2009 Mar;29(1):69-73.
Heparin is used for thromboprophylaxis in patients on hemodialysis, hemofiltration or continuous renal replacement therapies. Heparin-related immediate-type hypersensitivity reactions such as urticaria, angioedema or bronchospasm are very rare, and only... -
- CITED
-
- Close
- SHARE
-
- Close
- The Long-Term Clinical Outcomes of Low Molecular Weight Heparin Combined with Platelet Glycoprotein IIb/IIIa Inhibitor in Patients with Acute Coronary Syndrome
-
Kim JH, Jeong MH, Rhew JY, Yang B, Sim DS, Lim SY, Hong YJ, Park OY, Park WS, Kim W, Ahn YK, Moon Y, Cho JG, Chun J
- KMID: 2093885
- Korean Circ J.
- 2003 Jul;33(7):559-567.
- doi: 10.4070/kcj.2003.33.7.559
BACKGROUND AND OBJECTIVES: Platelet activation and aggregation, with resultant arterial thrombus formation, play pivotal roles in the pathophysiology of acute coronary syndrome (ACS). The efficacy of tirofiban, a specific inhibitor... -
- CITED
-
- Close
- SHARE
-
- Close
- The long-term clinical outcomes of low molecular weight heparin in patients with unstable angina underwent percutaneous coronary intervention
-
Hong YJ, Jeong MH, Lee SH, Park OY, Kim JH, Kim W, Rhew JY, Ahn YK, Cho JG, Park JC, Suh SP, Ahn BH, Kim SH, Kang JC
- KMID: 2252858
- Korean J Med.
- 2002 Aug;63(2):158-168.
BACKGROUND: Antithrombotic therapy with heparin reduces the rate of ischemic events in patients with acute coronary syndrome. Low-molecular-weight heparin (LMWH), given subcutaneously twice daily, has a more predictable anticoagulant effect... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Low-Molecular-Weight Heparin on Anticoagulation and Lipid Profiles in Hemodialysis Patients
-
Park JH, Kim MK, Go GJ, Lee MA, Kim BS, Kim YO, Yoon SA, Kim YS, Bang BK
- KMID: 1968474
- Korean J Nephrol.
- 1999 Jan;18(1):134-140.
Although heparin has over the years proven to be a reliable anticoagulant, there are still several undesirable side effects including dyslipidemia. Several recent publications have suggested that a low-molecular-weight heparin(LMWH)... -
- CITED
-
- Close
- SHARE
-
- Close
- Intimal Hyperplasia in a Rat Model after Balloon Induced Arterial Injury
-
Jung SH, Kwun WH, Suh BY, Kwun KB, Kim YJ
- KMID: 2324534
- J Korean Soc Vasc Surg.
- 2001 Apr;17(1):8-15.
PURPOSE: Intimal hyperplasia is an exaggerated proliferating response to arterial injury and can lead to occlusion and thromboses of arteries and bypass graft following arterial surgery or angioplasty. Medial smooth... -
- CITED
-
- Close
- SHARE
-
- Close
